Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - Results from the MONICA Augsburg and the PROCAM cohorts

European Heart Journal

Volumn 24, Issue 10, 2003, Pages 937-945

  Hense, Hans Werner ^a   Schulte, Helmut ^a   Löwel, Hannelore ^b   Assmann, Gerd ^a   Keil, Ulrich ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Coronary risk prediction; Primary prevention; Prospective study

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; GERMANY; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUDDEN DEATH;

ADULT; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTORS;

EID: 0038561090     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00081-2     Document Type: Article

References (30)

1. Jackson R. Guidelines on preventing cardiovascular disease in clinical practice. BMJ 2000;320:659-61.
2. Grundy SM, Pasternak R, Greenland P et al. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481-92.
3. Wood D, De Backer G, Faergeman O et al. Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J 1998;19:1434-503.
4. JNC VI. The 6th report of the joint national committee on detection, prevention, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
5. The International Task Force for Prevention of Coronary Heart Disease. Coronary heart disease: reducing the risk. The scientific background for primary and secondary prevention of coronary heart disease. Nutr Metab Cardiovasc Dis 1998;8:212-71.
6. Ramsay LE, Williams B, Johnston GD et al. British hypertension society guidelines for hypertension management 1999: summary. BMJ 1999;319;630-5.
7. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
8. Anderson KM, Odell PM, Wilson PW et al. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-8.
9. Anderson KM, Wilson PW, Odell PM et at. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
10. Wilson PW, D'Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
11. Kannet WB. Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure. Cardiovasc Drugs Ther 1987;11(Suppl 1);199-212.
12. Menotti A, Lanti M, Puddu PE et al. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart 2000;84:238-44.
13. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000;21:365-70.
14. Laurier D, Nguyen PC, Cazetles B et al. Estimation of CHD risk in a French working population using a modified Framingham model. The PCV-METRA Group. J Clin Epidemiol 1994;47:1353-64.
15. Ramachandran S, French JM, Vanderpump MP et at. Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ 2000;320:676-7.
16. Wallis EJ, Ramsay LE, Ul-Haq I et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ 2000;320:671-6.
17. Haq IU, Ramsay LE, Yeo WW et al. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999;81:40-6.
18. Haq IU, Ramsay LE, Jackson PR et al. Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods. QJM 1999;92:379-85.
19. WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates and case fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
20. Keil U, Liese AD, Hense HW et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg Cohort Study 1984-1992. Eur Heart J 1998;19:1197-207.
21. Keil U, Filipiak B, Döring A et al. Monitoring trends and determinants in cardiovascular disease: results of the MONICA Project Augsburg, 1985-90. MMWR Morb Mortal Wkly Rep 1992;41:171-80.
22. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999;353:1547-57.
23. Schulte H, Cullen P, Assmann G. Obesity, mortality and cardiovascular disease in the Münster Heart Study (PROCAM). Atherosclerosis 1999;144:199-209.
24. Abbott R, McGee DM. The Framingham Study: an epidemiological investigation of cardiovascular disease. Section 37: The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. In: Kannel WB, Wolf PA, Garrison RJ, editors. NIH-Publication No. 87-2284. U.S. Department of Health and Human Services; 1987. p. 9-12.
25. Thomsen TF, McGee DM, Davidsen M et al. A cross-validation of risk scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002;31:817-22.
26. Hanley JA, McNeil BJ. A method of comparing the areas under the receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
27. Miller ME, Hui SL, Tierney WM. Validation techniques for logistic regression models. Stat Med 1991;10:1213-26.
28. Kannel WB, Abbott R. Incidence and prognosis of unrecognised myocardial infarction. An update on the Framingham study. N Engl J Med 1984;311:1144-7.
29. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation 2002;105:310-5.
30. D'Agostino RB, Grundy S, Sullivan LM et al. Validation of the Framingham coronary heart disease prediction scores. Results from a multiple ethnic groups investigation. JAMA 2001;286:180-7.